Workflow
昊帆生物: 民生证券股份有限公司关于苏州昊帆生物股份有限公司2025年半年度跟踪报告
Zheng Quan Zhi Xing·2025-09-05 16:13

Group 1 - The sponsor, Minsheng Securities Co., Ltd., has conducted timely reviews of the company's information disclosure documents with no instances of delayed reviews [1] - The company has established and effectively executed relevant regulations, including those to prevent related parties from occupying company resources and managing raised funds [1] - The sponsor has conducted four inquiries into the company's raised funds special account, confirming that the project progress aligns with the disclosed information [1] Group 2 - There were no reported issues regarding risk investments, entrusted financial management, or financial assistance [1] - The company and its shareholders have fulfilled their commitments without any unresolved issues [2] - No regulatory measures or corrective actions were reported concerning the company [2]